1. Show article details.

    Kindred Healthcare Board of Directors Declares Quarterly Cash Dividend of $0.12 Per Common Share and Approves Scheduled Installment Payment on 7.50% Tangible Equity Units

    Business Wire – 4:35 PM ET 02/26/2015

    Kindred Healthcare, Inc. (KND) today announced that its Board of Directors approved the payment of the regular quarterly cash dividend to its common shareholders. Kindred also today announced that its Board of Directors has approved payment of the scheduled March 1, 2015 installment payment on the Company’s 7.50% Tangible Equity Units.

  2. Show article details.

    Kindred Healthcare Announces Fourth Quarter 2014 Results

    Business Wire – 4:30 PM ET 02/26/2015

    Kindred Healthcare, Inc. (KND) today announced its operating results for the fourth quarter and year ended December 31, 2014. All financial and statistical information included in this press release reflects the continuing operations of the Company’s businesses for all periods presented unless otherwise indicated.

  3. Show article details.

    Kindred’s Fourth Quarter Conference Call Scheduled for February 27

    Business Wire – 5:00 PM ET 02/17/2015

    Kindred Healthcare, Inc. (KND) announced today that it will provide an online, real-time webcast of its conference call covering fourth quarter and year-end 2014 operating results on Friday, February 27, 2015.

  4. Show article details.

    Kindred Names Dr. Marc Rothman Senior Chief Medical Officer

    Business Wire – 5:30 PM ET 02/11/2015

    Kindred Healthcare, Inc. (KND) today announced the promotion of Dr. Marc Rothman to Senior Vice President and Senior Chief Medical Officer for the Company, effective immediately. Dr. Rothman brings more than a decade of expertise in internal and geriatric medicine, post-acute and long-term care, and clinical epidemiology.

  5. Show article details.

    Kindred Healthcare Completes Acquisition of Gentiva Health Services Creating Nation-Wide Integrated Care Delivery System

    Business Wire – 4:30 PM ET 02/02/2015

    Kindred Healthcare, Inc. (KND) today announced that it has completed its acquisition of Gentiva Health Services, Inc., in a transaction valued at $1.8 billion, including the assumption of net debt.

  6. Show article details.

    Kindred Healthcare Announces Receipt of Consents to Amend Indenture

    Business Wire – 5:00 PM ET 01/30/2015

    Kindred Healthcare, Inc. (KND) today reported the results of its previously announced solicitation of consents to certain proposed amendments to the indenture, dated as of April 9, 2014, governing the Company’s 6.375% Senior Notes due 2022, CUSIP 494580 AC7 and U4946LAA7, pursuant to its Consent Solicitation Statement, dated as of January 15, 2015.

  7. Show article details.

    Kindred Healthcare Announces Results of the Exchange Offer for Its 6.375% Senior Notes Due 2022

    Business Wire – 5:00 PM ET 01/29/2015

    Kindred Healthcare, Inc. (KND) today announced the final results of its registered exchange offer for all of its outstanding 6.375% Senior Notes due 2022, which were not registered under the Securities Act of 1933, as amended, for an equal principal amount of its 6.375% Senior Notes due 2022, which have been registered under the Securities Act.

  8. Show article details.

    Kindred Healthcare Extends Expiration Date and Increases Cash Consent Payment in Consent Solicitation

    Business Wire – 4:00 PM ET 01/28/2015

    Kindred Healthcare, Inc. (KND) today announced that it has extended the expiration time and increased the cash consent payment for its previously announced solicitation of consents to certain proposed amendments to the indenture, dated as of April 9, 2014, governing the Company’s 6.375% Senior Notes due 2022, CUSIP 494580 AC7 and U4946LAA7, pursuant to its Consent Solicitation Statement, dated as o...

  9. Show article details.

    Kindred Healthcare Extends Expiration Date in Consent Solicitation

    Business Wire – 8:00 AM ET 01/28/2015

    Kindred Healthcare, Inc. (KND) today announced that it has extended the expiration time for its previously announced solicitation of consents to certain proposed amendments to the indenture, dated as of April 9, 2014, governing the Company’s 6.375% Senior Notes due 2022, CUSIP 494580 AC7 and U4946LAA7, pursuant to its Consent Solicitation Statement, dated as of January 15, 2015.

  10. Show article details.

    Akorn Set to Join the S&P MidCap 400; United Insurance Holdings, ANI Pharmaceuticals to Join the S&P SmallCap 600

    PR Newswire – 5:46 PM ET 01/27/2015

    NEW YORK S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices: Akorn (AKRX) manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals. United Insurance Holdings (UIHC) operates as a property and casualty insurance company.

  11. Show article details.

    Kindred Names Kent H. Wallace Executive Vice President and Chief Operating Officer

    Business Wire – 5:30 PM ET 01/26/2015

    Kindred Healthcare, Inc. (KND) today announced that it has named Kent H. Wallace Executive Vice President and Chief Operating Officer, effective February 2, 2015. Mr. Wallace will report to Benjamin A. Breier, President and Chief Operating Officer. Mr. Wallace, 59, has more than 25 years of leadership experience in a wide range of healthcare companies.

  12. Show article details.

    Kindred Healthcare Announces Gentiva Health Services Stockholder Approval of Combination

    Business Wire – 4:15 PM ET 01/22/2015

    Kindred Healthcare, Inc. (KND) announced that, at the Special Meeting of Stockholders of Gentiva Health Services, Inc. held today, the Gentiva stockholders approved Gentiva’s combination with Kindred.

  13. Show article details.

    Gentiva Health Services Stockholders Approve Combination with Kindred Healthcare

    Business Wire – 4:03 PM ET 01/22/2015

    Gentiva Health Services, Inc. (GTIV) today announced that all proposals necessary for the combination with Kindred Healthcare, Inc. (KND) were approved by Gentiva’s stockholders at the Company’s Special Meeting of Stockholders held today.

  14. Show article details.

    Kindred Healthcare Commences Consent Solicitation to Amend Indenture

    Business Wire – 9:30 AM ET 01/15/2015

    Kindred Healthcare, Inc. (KND) today announced that it has commenced soliciting consents to certain proposed amendments to the indenture, dated as of April 9, 2014, governing the Company’s 6.375% Senior Notes due 2022, CUSIP 494580 AC7 and U4946LAA7, pursuant to a Consent Solicitation Statement, dated as of January 15, 2015.

  15. Show article details.

    Kindred to Present at the J.P. Morgan Healthcare Conference

    Business Wire – 5:00 PM ET 01/07/2015

    Kindred Healthcare, Inc. (KND) today announced that Benjamin A. Breier, President and Chief Operating Officer, will make a presentation regarding the Company at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 14, 2015, at 9:30 a.m. Pacific Time / 12:30 p.m. The presentation is being audio webcast and can be accessed at the Company’s website at h...

  16. Show article details.

    Kindred Acquires Centerre Healthcare

    Business Wire – 8:00 AM ET 01/02/2015

    Kindred Healthcare, Inc. (KND) today announced that it has completed the previously announced acquisition of Centerre Healthcare Corporation, a national company dedicated to operating Inpatient Rehabilitation Hospitals, for a purchase price of approximately $195 million in cash.

  17. Show article details.

    Kindred Healthcare Commences Registered Exchange Offer for Its 6.375% Senior Notes Due 2022

    Business Wire – 4:30 PM ET 12/29/2014

    Kindred Healthcare, Inc. (KND) today announced the commencement of an exchange offer for all of its outstanding 6.375% Senior Notes due 2022, which are not registered under the Securities Act of 1933, as amended, for an equal principal amount of its 6.375% Senior Notes due 2022, which have been registered under the Securities Act.

  18. Show article details.

    Ventas Reaches Favorable Agreement with Kindred Healthcare Regarding Transition of Nine Post-Acute Facilities and Modifications to Certain Master Leases

    Business Wire – 7:04 AM ET 12/29/2014

    Ventas, Inc. (VTR) said today that it and Kindred Healthcare, Inc. (KND) have entered into an agreement to transition the operations of nine post-acute facilities.

  19. Show article details.

    Kindred Healthcare Announces Agreement with Ventas to Transition Operations for Nine Non-Strategic Nursing Centers and Amend Master Leases

    Business Wire – 7:00 AM ET 12/29/2014

    Kindred Healthcare, Inc. (KND) today announced it has entered into an agreement with Ventas, Inc. (VTR) to transition the operations under the leases for nine non-strategic nursing centers.

  20. Show article details.

    Kindred Healthcare Closes $1.35 Billion Senior Unsecured Notes Offering; Announces February 2 Target Closing Date for Merger with Gentiva Now That All Financing is Complete

    Business Wire – 4:30 PM ET 12/18/2014

    Kindred Healthcare, Inc. (KND) today announced that it has closed its previously announced offering of $1.35 billion aggregate principal amount of senior unsecured notes.

Page:

Today's and Upcoming Events

  • Mar
    9

    KND ex-Dividend for $0.12 on 3/9/2015

    • Announce Date: 2/26/2015
    • Record Date: 3/11/2015
    • Pay Date: 4/1/2015

Past Events (last 90 days)

  • Feb
    27

    KND Earnings Conference Call at 10:00 AM Listen

  • Feb
    26

    KND announced Q4 earnings of $0.26 per share (vs. $0.283) at 2/26/2015 4:30:00 PM ET

Data provided by Wall Street Horizon, Inc. © 2015

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.